APA (7th ed.) Citation

Mueller, J., Haberland, A., Becker, N., Wenzel, K., Wallukat, G., Goettel, P., . . . Davideit, H. (2018). THE DNA-BASED THERAPEUTIC AGENT BC 007 COMPLETELY NEUTRALIZES AGONISTIC AUTOANTIBODIES DIRECTED AGAINST β1-ADRENOCEPTORS: RESULTS OF A PHASE 1 TRIAL. Journal of the American College of Cardiology (JACC), 71, A645. https://doi.org/10.1016/S0735-1097(18)31186-0

Chicago Style (17th ed.) Citation

Mueller, Johannes, et al. "THE DNA-BASED THERAPEUTIC AGENT BC 007 COMPLETELY NEUTRALIZES AGONISTIC AUTOANTIBODIES DIRECTED AGAINST β1-ADRENOCEPTORS: RESULTS OF A PHASE 1 TRIAL." Journal of the American College of Cardiology (JACC) 71 (2018): A645. https://doi.org/10.1016/S0735-1097(18)31186-0.

MLA (9th ed.) Citation

Mueller, Johannes, et al. "THE DNA-BASED THERAPEUTIC AGENT BC 007 COMPLETELY NEUTRALIZES AGONISTIC AUTOANTIBODIES DIRECTED AGAINST β1-ADRENOCEPTORS: RESULTS OF A PHASE 1 TRIAL." Journal of the American College of Cardiology (JACC), vol. 71, 2018, p. A645, https://doi.org/10.1016/S0735-1097(18)31186-0.